Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
26
-
Total 13F shares, excl. options
-
11M
-
Shares change
-
+322K
-
Total reported value, excl. options
-
$7.89M
-
Value change
-
+$210K
-
Number of buys
-
11
-
Number of sells
-
-9
-
Price
-
$0.72
Significant Holders of Vincerx Pharma, Inc. - Common Stock (VINC) as of Q3 2024
31 filings reported holding VINC - Vincerx Pharma, Inc. - Common Stock as of Q3 2024.
Vincerx Pharma, Inc. - Common Stock (VINC) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11M shares
.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (2.7M shares), Prosight Management, LP (2.21M shares), SAGE RHINO CAPITAL LLC (1.7M shares), Rock Springs Capital Management LP (892K shares), Point72 Asset Management, L.P. (674K shares), GOLDMAN SACHS GROUP INC (631K shares), VANGUARD GROUP INC (627K shares), ExodusPoint Capital Management, LP (542K shares), MARSHALL WACE, LLP (354K shares), and GEODE CAPITAL MANAGEMENT, LLC (251K shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.